Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Nominated Bulk Substances for Compounding and Nominated Products for the Demonstrably Difficult to Compound List Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Nominated Bulk Substances for Compounding and Nominated Products for the Demonstrably Difficult to Compound List Report